• Home
  • Publications
  • Clinical Trials
  • KLH in News
  • About KLH
  • Contact

KLH Site
  • Home
  • Publications
  • Clinical Trials
  • KLH in News
  • About KLH
  • Contact

Top
  • Home
  • Publications
  • Clinical Trials
  • KLH in News
  • About KLH
  • Contact
Search KLH Site
  • Clinical Trials RSS
  • Publications RSS
  • KLH in News RSS
Find Trials by Tags
Adjuvant GM-CSF (33) Adjuvant GPI-0100 (1) Adjuvant KLH (3) Adjuvant Oil / Surfactant (2) Adjuvant OPT-821/822 (7) Adjuvant QS-21 (16) BCI-ImmuneActivator (2) Bevacizumab (Avastin) (1) Dendritic Cell (25) Diagnostic Antigen (26) DTH (7) id-KLH (26) IL15 (1) Immucothel (3) Immune Response - Cellular (7) Immune Response - Humoral (12) KLH-Conjugate (70) KLH-EGFR (5) KLH-FITC (2) KLH-Ganglioside (11) KLH-Globo H (9) KLH-IFNa-Kinoid (1) KLH-Lewis-y (2) KLH-MUC (10) KLH-SLe (1) KLH-sTn (4) KLH-TF (5) KLH-Tn (5) KLH-TnFa-Kinoid (4) KLH-Tn-MUC (1) KLH-WT1 (3) Natalizumab (Tysabri) (1) Oral KLH (1) Rindopepimut (CDX-110) (6) Rituximab (Rituxan) (10) Temozolomide (Temodar) (1) Therapeutic Vaccine (96) Therapeutics - KLH Alone (3)
Terms and Privacy
  • Important Information
    • Read Terms of Use and Privacy Policy
Clinical Trial Categories
  • Age & Physical Activity (1)
  • Arthritis (2)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (13)
  • Cancer - Breast (6)
  • Cancer - Colon (1)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (7)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (4)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (13)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (9)
  • Cancer - Other (4)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (11)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (1)
  • Healthy (2)
  • Hepatitis C (2)
  • HIV (4)
  • Immune Disease - Autoimmune (8)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Liver Disease (2)
  • Lupus Erythematosus (2)
  • Multiple Sclerosis (1)
  • Pediatric (2)
  • Transplant (1)
Tuesday
Jun012010

NCT01241682

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

Conditions: Malignant Pleural Mesothelioma
Sponsors: Erasmus Medical Center
Phase I

Date: DateJune 1, 2010 | Reference3 References
Categories CategoryCancer - Mesothelioma
Tags TagDTH, TagDendritic Cell, TagDiagnostic Antigen, TagTherapeutic Vaccine

PrintView Printer Friendly Version

EmailEmail Article to Friend

References (3)

References allow you to track sources for this article, as well as articles that were written in response to this article.
  • Source
    Source: J Biomed Biotechnol. 2010;2010:798467. Epub 2010 May 23.
  • Source
    Source: Am J Respir Crit Care Med. 2010 Jun 15;181(12):1383-90. Epub 2010 Feb 18.
  • Source
    Source: Am J Respir Crit Care Med. 2005 May 15;171(10):1168-77. Epub 2005 Mar 11.
Copyright © 2012-2013 Stellar Biotechnologies, Inc. All rights reserved. www.stellarbiotech.com See Terms of Use & Privacy Policy.